References
- Knudson A. G. Two genetic hits (more or less) to cancer. Nat. Rev., Cancer 2001; 1: 157–162
- Knudson A. G. Chasing the cancer demon. Annu. Rev. Genet. 2000; 34: 1–19, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Bourneville D. M. Sclérose tubéreuse des circonvolutions cérébrales: idiotie et épilepsie hémiplégique. Arch. Neurol. (Paris) 1880; 1: 81–91
- Gomez M. R. Definition and criteria for diagnosis. Tuberous Sclerosis Complex, M. R. Gomez, J. R. Sampson, V. H. Whittemore. Oxford University Press, New York 1999; 10–23
- Shepherd C. W., Beard C. M., Gomez M. R., Kurland L. T., Whisnant J. P. Tuberous sclerosis complex in Olmsted County, Minnesota, 1950–1989. Arch. Neurol. 1991; 48: 400–401, [PUBMED], [INFOTRIEVE]
- Webb D. W., Fryer A. E., Osborne J. P. Morbidity associated with tuberous sclerosis: a population study. Dev. Med. Child Neurol. 1996; 38: 146–155, [PUBMED], [INFOTRIEVE], [CSA]
- Crino P. B., Trojanowski J. Q., Dichter M. A., Eberwine J. Embryonic neuronal markers in tuberous sclerosis: single-cell molecular pathology. Proc. Natl. Acad. Sci. U. S. A. 1996; 93: 14152–14157, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Hirose T., Scheithauer B. W., Lopes M. B., Gerber H. A., Altermatt H. J., Hukee M. J., VandenBerg S. R., Charlesworth J. C. Tuber and subependymal giant cell astrocytoma associated with tuberous sclerosis: an immunohistochemical, ultrastructural, and immunoelectron and microscopic study. Acta. Neuropathol. (Berl) 1995; 90: 387–399, [CSA]
- Bjornsson J., Short M. P., Kwiatkowski D. J., Henske E. P. Tuberous sclerosis-associated renal cell carcinoma. Clinical, pathological, and genetic features. Am. J. Pathol. 1996; 149: 1201–1208, [PUBMED], [INFOTRIEVE]
- Yu J., Astrinidis A., Henske E. P. Chromosome 16 loss of heterozygosity in tuberous sclerosis and sporadic lymphangiomyomatosis. Am. J. Respir. Crit. Care Med. 2001; 164: 1537–1540, [PUBMED], [INFOTRIEVE], [CSA]
- van Slegtenhorst M., de Hoogt R., Hermans C., Nellist M., Janssen B., Verhoef S., Lindhout D., van den Ouweland A., Halley D., Young J., et al. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 1997; 277: 805–808, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Consortium. Identification and characterization of the tuberous sclerosis gene on chromosome 16. The European Chromosome 16 Tuberous Sclerosis Consortium. Cell 1993; 75: 1305–1315
- Brook-Carter P. T., Peral B., Ward C. J., Thompson P., Hughes J., Maheshwar M. M., Nellist M., Gamble V., Harris P. C., Sampson J. R. Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease—a contiguous gene syndrome. Nat. Genet. 1994; 8: 328–332, [CROSSREF]
- Harris P. C. The TSC2/PKD1 contiguous gene syndrome. Contrib. Nephrol. 1997; 122: 76–82, [PUBMED], [INFOTRIEVE], [CSA]
- Dabora S. L., Jozwiak S., Franz D. N., Roberts P. S., Nieto A., Chung J., Choy Y. S., Reeve M. P., Thiele E., Egelhoff J. C., et al. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am. J. Hum. Genet. 2001; 68: 64–80, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Jones A. C., Shyamsundar M. M., Thomas M. W., Maynard J., Idziaszczyk S., Tomkins S., Sampson J. R., Cheadle J. P. Comprehensive mutation analysis of TSC1 and TSC2 and phenotypic correlations in 150 families with tuberous sclerosis. Am. J. Hum. Genet. 1999; 64: 1305–1315, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Verhoef S., Bakker L., Tempelaars A. M., Hesseling-Janssen A. L., Mazurczak T., Jozwiak S., Fois A., Bartalini G., Zonnenberg B. A., van Essen A. J., et al. High rate of mosaicism in tuberous sclerosis complex. Am. J. Hum. Genet. 1999; 64: 1632–1637, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Yates J. R., van Bakel I., Sepp T., Payne S. J., Webb D. W., Nevin N. C., Green A. J. Female germline mosaicism in tuberous sclerosis confirmed by molecular genetic analysis. Hum. Mol. Genet. 1997; 6: 2265–2269, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Green A. J., Johnson P. H., Yates J. R. The tuberous sclerosis gene on chromosome 9q34 acts as a growth suppressor. Hum. Mol. Genet. 1994; 3: 1833–1834, [PUBMED], [INFOTRIEVE], [CSA]
- Henske E. P., Wessner L. L., Golden J., Scheithauer B. W., Vortmeyer A. O., Zhuang Z., Klein-Szanto A. J., Kwiatkowski D. J., Yeung R. S. Loss of tuberin in both subependymal giant cell astrocytomas and angiomyolipomas supports a two-hit model for the pathogenesis of tuberous sclerosis tumors. Am. J. Pathol. 1997; 151: 1639–1647, [PUBMED], [INFOTRIEVE]
- Hengstschlager M., Rodman D. M., Miloloza A., Hengstschlager-Ottnad E., Rosner M., Kubista M. Tuberous sclerosis gene products in proliferation control. Mutat. Res. 2001; 488: 233–239, [PUBMED], [INFOTRIEVE], [CSA]
- Han S., Santos T. M., Puga A., Roy J., Thiele E. A., McCollin M., Stemmer-Rachamimov A., Ramesh V. Phosphorylation of tuberin as a novel mechanism for somatic inactivation of the tuberous sclerosis complex proteins in brain lesions. Cancer Res. 2004; 64: 812–816, [PUBMED], [INFOTRIEVE]
- Plank T. L., Yeung R. S., Henske E. P. Hamartin, the product of the tuberous sclerosis 1 (TSC1) gene, interacts with tuberin and appears to be localized to cytoplasmic vesicles. Cancer Res. 1998; 58: 4766–4770, [PUBMED], [INFOTRIEVE]
- van Slegtenhorst M., Nellist M., Nagelkerken B., Cheadle J., Snell R., van den Ouweland A., Reuser A., Sampson J., Halley D., van der Sluijs P. Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products. Hum. Mol. Genet. 1998; 7: 1053–1057, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Potter C. J., Huang H., Xu T. Drosophila Tsc1 functions with Tsc2 to antagonize insulin signaling in regulating cell growth, cell proliferation, and organ size. Cell 2001; 105: 357–368, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Hodges A. K., Li S., Maynard J., Parry L., Braverman R., Cheadle J. P., DeClue J. E., Sampson J. R. Pathological mutations in TSC1 and TSC2 disrupt the interaction between hamartin and tuberin. Hum. Mol. Genet. 2001; 10: 2899–2905, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Nellist M., van Slegtenhorst M. A., Goedbloed M., van den Ouweland A. M., Halley D. J., van der Sluijs P. Characterization of the cytosolic tuberin-hamartin complex. Tuberin is a cytosolic chaperone for hamartin. J. Biol. Chem. 1999; 274: 35647–35652, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Yamamoto Y., Jones K. A., Mak B. C., Muehlenbachs A., Yeung R. S. Multicompartmental distribution of the tuberous sclerosis gene products, hamartin and tuberin. Arch. Biochem. Biophys. 2002; 404: 210–217, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Aicher L. D., Campbell J. S., Yeung R. S. Tuberin phosphorylation regulates its interaction with hamartin. Two proteins involved in tuberous sclerosis. J. Biol. Chem. 2001; 276: 21017–21021, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Nellist M., Verhaaf B., Goedbloed M. A., Reuser A. J., van den Ouwel A. M., Halley D. J. TSC2 missense mutations inhibit tuberin phosphorylation and prevent formation of the tuberin-hamartin complex. Hum. Mol. Genet. 2001; 10: 2889–2898, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Inoki K., Li Y., Zhu T., Wu J., Guan K. L. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat. Cell Biol. 2002; 4: 648–657, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Olsson P. G., Schofield J. N., Edwards Y. H., Frischauf A. M. Expression and differential splicing of the mouse TSC2 homolog. Mamm. Genome 1996; 7: 212–215, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Murthy V., Haddad L. A., Smith N., Pinney D., Tyszkowski R., Brown D., Ramesh V. Similarities and differences in the subcellular localization of hamartin and tuberin in the kidney. Am. J. Physiol., Renal Physiol. 2000; 278: F737–F746, [CSA]
- Wienecke R., Maize J. C., Jr., Reed J. A., de Gunzburg J., Yeung R. S., DeClue J. E. Expression of the TSC2 product tuberin and its target Rap1 in normal human tissues. Am. J. Pathol. 1997; 150: 43–50, [PUBMED], [INFOTRIEVE]
- Jones K. A., Jiang X., Yamamoto Y., Yeung R. S. Tuberin is a component of lipid rafts and mediates caveolin-1 localization: role of TSC2 in post-Golgi transport. Exp. Cell Res. 2004; 295: 512–524, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Lou D., Griffith N., Noonan D. J. The tuberous sclerosis 2 gene product can localize to nuclei in a phosphorylation-dependent manner. Mol. Cell. Biol. Res. Commun. 2001; 4: 374–380, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Catania M. G., Mischel P. S., Vinters H. V. Hamartin and tuberin interaction with the G2/M cyclin-dependent kinase CDK1 and its regulatory cyclins A and B. J. Neuropathol. Exp. Neurol. 2001; 60: 711–723, [PUBMED], [INFOTRIEVE], [CSA]
- Gao X., Pan D. TSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growth. Genes Dev. 2001; 15: 1383–1392, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Potter C. J., Xu T. Mechanisms of size control. Curr. Opin. Genet. Dev. 2001; 11: 279–286, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Potter C. J., Pedraza L. G., Xu T. Akt regulates growth by directly phosphorylating Tsc2. Nat. Cell Biol. 2002; 4: 658–665, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Gao X., Zhang Y., Arrazola P., Hino O., Kobayashi T., Yeung R. S., Ru B., Pan D. Tsc tumour suppressor proteins antagonize amino-acid-TOR signalling. Nat. Cell Biol. 2002; 4: 699–704, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Goncharova E. A., Goncharov D. A., Eszterhas A., Hunter D. S., Glassberg M. K., Yeung R. S., Walker C. L., Noonan D., Kwiatkowski D. J., Chou M. M., et al. Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation. A role for the TSC2 tumor suppressor gene in pulmonary lymphangioleiomyomatosis (LAM). J. Biol. Chem. 2002; 277: 30958–30967, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Manning B. D., Tee A. R., Logsdon M. N., Blenis J., Cantley L. C. Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. Mol. Cell 2002; 10: 151–162, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Dan H. C., Sun M., Yang L., Feldman R. I., Sui X. M., Ou C. C., Nellist M., Yeung R. S., Halley D. J., Nicosia S. V., et al. Phosphatidylinositol 3-kinase/Akt pathway regulates tuberous sclerosis tumor suppressor complex by phosphorylation of tuberin. J. Biol. Chem. 2002; 277: 35364–35370, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Jaeschke A., Hartkamp J., Saitoh M., Roworth W., Nobukuni T., Hodges A., Sampson J., Thomas G., Lamb R. Tuberous sclerosis complex tumor suppressor-mediated S6 kinase inhibition by phosphatidylinositide-3-OH kinase is mTOR independent. J. Cell. Biol. 2002; 159: 217–224, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Reynolds T. H.T., Bodine S. C., Lawrence J. C., Jr. Control of Ser2448 phosphorylation in the mammalian target of rapamycin by insulin and skeletal muscle load. J. Biol. Chem. 2002; 277: 17657–17662, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Kwiatkowski D. J., Zhang H., Bandura J. L., Heiberger K. M., Glogauer M., el-Hashemite N., Onda H. A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells. Hum. Mol. Genet. 2002; 11: 525–534, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Wienecke R., Konig A., DeClue J. E. Identification of tuberin, the tuberous sclerosis-2 product. Tuberin possesses specific Rap1GAP activity. J. Biol. Chem. 1995; 270: 16409–16414, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Xiao G. H., Shoarinejad F., Jin F., Golemis E. A., Yeung R. S. The tuberous sclerosis 2 gene product, tuberin, functions as a Rab5 GTPase activating protein (GAP) in modulating endocytosis. J. Biol. Chem. 1997; 272: 6097–6100, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Saucedo L. J., Gao X., Chiarelli D. A., Li L., Pan D., Edgar B. A. Rheb promotes cell growth as a component of the insulin/TOR signalling network. Nat. Cell Biol. 2003; 5: 566–571, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Stocker H., Radimerski T., Schindelholz B., Wittwer F., Belawat P., Daram P., Breuer S., Thomas G., Hafen E. Rheb is an essential regulator of S6K in controlling cell growth in Drosophila. Nat. Cell Biol. 2003; 5: 559–565, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Zhang Y., Gao X., Saucedo L. J., Ru B., Edgar B. A., Pan D. Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins. Nat. Cell Biol. 2003; 5: 578–581, [PUBMED], [INFOTRIEVE]
- Inoki K., Li Y., Xu T., Guan K. L. Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev. 2003; 17: 1829–1834, [PUBMED], [INFOTRIEVE]
- Tee A. R., Manning B. D., Roux P. P., Cantley L. C., Blenis J. Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb. Curr. Biol. 2003; 13: 1259–1268, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Castro A. F., Rebhun J. F., Clark G. J., Quilliam L. A. Rheb binds tuberous sclerosis complex 2 (TSC2) and promotes S6 kinase activation in a rapamycin- and farnesylation-dependent manner. J. Biol. Chem. 2003; 278: 32493–32496, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Garami A., Zwartkruis F. J., Nobukuni T., Joaquin M., Roccio M., Stocker H., Kozma S. C., Hafen E., Bos J. L., Thomas G. Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2. Mol. Cell 2003; 11: 1457–1466, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Rohde J., Heitman J., Cardenas M. E. The TOR kinases link nutrient sensing to cell growth. J. Biol. Chem. 2001; 276: 9583–9586, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Hara K., Maruki Y., Long X., Yoshino K., Oshiro N., Hidayat S., Tokunaga C., Avruch J., Yonezawa K. Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell 2002; 110: 177–189, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Kim D. H., Sarbassov dos D., Ali S. M., Latek R. R., Guntur K. V., Erdjument-Bromage H., Tempst P., Sabatini D. M. GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR. Mol. Cell 2003; 11: 895–904, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Loewith R., Jacinto E., Wullschleger S., Lorberg A., Crespo J. L., Bonenfant D., Oppliger W., Jenoe P., Hall M. N. Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control. Mol. Cell 2002; 10: 457–468, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Schmidt A., Bickle M., Beck T., Hall M. N. The yeast phosphatidylinositol kinase homolog TOR2 activates RHO1 and RHO2 via the exchange factor ROM2. Cell 1997; 88: 531–542, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Choi J. H., Adames N. R., Chan T. F., Zeng C., Cooper J. A., Zheng X. F. TOR signaling regulates microtubule structure and function. Curr. Biol. 2000; 10: 861–864, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Choi J. H., Bertram P. G., Drenan R., Carvalho J., Zhou H. H., Zheng X. F. The FKBP12-rapamycin-associated protein (FRAP) is a CLIP-170 kinase. EMBO Rep. 2002; 3: 988–994, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Dennis P. B., Jaeschke A., Saitoh M., Fowler B., Kozma S. C., Thomas G. Mammalian TOR: a homeostatic ATP sensor. Science 2001; 294: 1102–1105, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Inoki K., Zhu T., Guan K. L. TSC2 mediates cellular energy response to control cell growth and survival. Cell 2003; 115: 577–590, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Kimball S. R., Shantz L. M., Horetsky R. L., Jefferson L. S. Leucine regulates translation of specific mRNAs in L6 myoblasts through mTOR-mediated changes in availability of eIF4E and phosphorylation of ribosomal protein S6. J. Biol. Chem. 1999; 274: 11647–11652, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Kenerson H. L., Aicher L. D., True L. D., Yeung R. S. Activated mammalian target of rapamycin pathway in the pathogenesis of tuberous sclerosis complex renal tumors. Cancer Res. 2002; 62: 5645–5650, [PUBMED], [INFOTRIEVE]
- Fingar D. C., Richardson C. J., Tee A. R., Cheatham L., Tsou C., Blenis J. mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E. Mol. Cell. Biol. 2004; 24: 200–216, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Nguyen-Vu P. A., Fackler I., Rust A., DeClue J. E., Sander C. A., Volkenandt M., Flaig M., Yeung R. S., Wienecke R. Loss of tuberin, the tuberous-sclerosis-complex-2 gene product is associated with angiogenesis. J. Cutan. Pathol. 2001; 28: 470–475, [CROSSREF], [CSA]
- Brugarolas J. B., Vazquez F., Reddy A., Sellers W. R., Kaelin W. G., Jr. TSC2 regulates VEGF through mTOR-dependent and -independent pathways. Cancer Cell. 2003; 4: 147–158, [PUBMED], [INFOTRIEVE], [CROSSREF]
- El-Hashemite N., Walker V., Zhang H., Kwiatkowski D. J. Loss of Tsc1 or Tsc2 induces vascular endothelial growth factor production through mammalian target of rapamycin. Cancer Res. 2003; 63: 5173–5177
- Liu M. Y., Poellinger L., Walker C. L. Up-regulation of hypoxia-inducible factor 2alpha in renal cell carcinoma associated with loss of Tsc-2 tumor suppressor gene. Cancer Res. 2003; 63: 2675–2680, [PUBMED], [INFOTRIEVE]
- Moon R. T., Bowerman B., Boutros M., Perrimon N. The promise and perils of Wnt signaling through beta-catenin. Science 2002; 296: 1644–1646, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Daniels D. L., Ekolf Spink K., Weis W. I. Beta-catenin: molecular plasticity and drug design. Trends Biochem. Sci. 2001; 26: 672–678, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Miller J. R., Hocking A. M., Brown J. D., Moon R. T. Mechanism and function of signal transduction by the Wnt/beta-catenin and Wnt/Ca2 + pathways. Oncogene 1999; 18: 7860–7872, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Mak B. C., Takemaru K., Kenerson H. L., Moon R. T., Yeung R. S. The tuberin-hamartin complex negatively regulates beta -catenin signaling activity. J. Biol. Chem. 2003; 278: 5947–5951, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Fukumoto S., Hsieh C. M., Maemura K., Layne M. D., Yet S. F., Lee K. H., Matsui T., Rosenzweig A., Taylor W. G., Rubin J. S., et al. Akt participation in the Wnt signaling pathway through Dishevelled. J. Biol. Chem. 2001; 276: 17479–17483, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Habas R., Kato Y., He X. Wnt/Frizzled activation of Rho regulates vertebrate gastrulation and requires a novel Formin homology protein Daam1. Cell 2001; 107: 843–854, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Marlow F., Topczewski J., Sepich D., Solnica-Krezel L. Zebrafish Rho kinase 2 acts downstream of Wnt11 to mediate cell polarity and effective convergence and extension movements. Curr. Biol. 2002; 12: 876–884, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Lamb R. F., Roy C., Diefenbach T. J., Vinters H. V., Johnson M. W., Jay D. G., Hall A. The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho [see comments]. Nat. Cell. Biol. 2000; 2: 281–287, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Astrinidis A., Cash T. P., Hunter D. S., Walker C. L., Chernoff J., Henske E. P. Tuberin, the tuberous sclerosis complex 2 tumor suppressor gene product, regulates Rho activation, cell adhesion and migration. Oncogene 2002; 21: 8470–8476, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Finlay G. A., Hunter D. S., Walker C. L., Paulson K. E., Fanburg B. L. Regulation of PDGF production and ERK activation by estrogen is associated with TSC2 gene expression. Am. J. Physiol., Cell Physiol. 2003; 285: C409–C418, [PUBMED], [INFOTRIEVE], [CSA]
- Zhang H., Cicchetti G., Onda H., Koon H. B., Asrican K., Bajraszewski N., Vazquez F., Carpenter C. L., Kwiatkowski D. J. Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR. J. Clin. Invest. 2003; 112: 1223–1233, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Henry K. W., Yuan X., Koszewski N. J., Onda H., Kwiatkowski D. J., Noonan D. J. Tuberous sclerosis gene 2 product modulates transcription mediated by steroid hormone receptor family members. J. Biol. Chem. 1998; 273: 20535–20539, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Birchenall-Roberts M. C., Fu T., Bang O. S., Dambach M., Resau J. H., Sadowski C. L., Bertolette D. C., Lee H. J., Kim S. J., Ruscetti F. W. Tuberous sclerosis complex 2 gene product interacts with human SMAD proteins: a molecular link of two tumor suppressor pathways. J. Biol. Chem. 2004; 25605–25613, [CROSSREF]
- Conery A. C.Y., Thompson E. A., Townsend C. M., Ko T. C., Luo K. Akt interacts directly with Smad3 to regulate the sensitivity to TGF-b-induced apoptosis. Nat. Cell. Biol. 2004; 6: 366–372, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Shah O. J., Hunter T. Critical role of T-loop and H-motif phosphorylation in the regulation of S6 kinase 1 by the tuberous sclerosis complex. J. Biol. Chem. 2004; 20816–20823, [CROSSREF]
- Nellist M., Goedbloed M. A., De Winter C., Verhaaf B., Jankie A., Reuser A. J., Van Den Ouweland A. M., Van Der Sluijs P., Halley D. J. Identification and characterization of the interaction between tuberin and 14-3-3zeta. J. Biol. Chem. 2002; 9: 9
- Li Y., Inoki K., Yeung R., Guan K. L. Regulation of TSC2 by 14-3-3 binding. J. Biol. Chem. 2002; 277: 44593–44596, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Li Y., Inoki K., Vacratsis P., Guan K. L. The p38 and MK2 kinase cascade phosphorylates tuberin, the tuberous sclerosis 2 gene product, and enhances its interaction with 14-3-3. J. Biol. Chem. 2003; 278: 13663–13671, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Shumway S. D., Li Y., Xiong Y. 14-3-3beta binds to and negatively regulates the tuberous sclerosis complex 2 (TSC2) tumor suppressor gene product, tuberin. J. Biol. Chem. 2003; 278: 2089–2092, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Soucek T., Yeung R. S., Hengstschlager M. Inactivation of the cyclin-dependent kinase inhibitor p27 upon loss of the tuberous sclerosis complex gene-2. Proc. Natl. Acad. Sci. U. S. A. 1998; 95: 15653–15658, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Fujita N., Sato S., Katayama K., Tsuruo T. Akt-dependent phosphorylation of p27Kip1 promotes binding to 14-3-3 and cytoplasmic localization. J. Biol. Chem. 2002; 277: 28706–28713, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Haddad L. A., Smith N., Bowser M., Niida Y., Murthy V., Gonzalez-Agosti C., Ramesh V. The TSC1 tumor suppressor hamartin interacts with neurofilament-L and possibly functions as a novel integrator of the neuronal cytoskeleton. J. Biol. Chem. 2002; 277: 44180–44186, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Astrinidis A., Senapedis W., Coleman T. R., Henske E. P. Cell cycle-regulated phosphorylation of hamartin, the product of the tuberous sclerosis complex 1 gene, by cyclin-dependent kinase 1/cyclin B. J. Biol. Chem. 2003; 278: 51372–51379, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Roberg K. J., Bickel S., Rowley N., Kaiser C. A. Control of amino acid permease sorting in the late secretory pathway of Saccharomyces cerevisiae by SEC13, LST4, LST7 and LST8. Genetics 1997; 147: 1569–1584, [PUBMED], [INFOTRIEVE], [CSA]
- Chen E. J., Kaiser C. A. Amino acids regulate the intracellular trafficking of the general amino acid permease of Saccharomycescerevisiae. Proc. Natl. Acad. Sci. U. S. A. 2002; 99: 14837–14842, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Chen E. J., Kaiser C. A. LST8 negatively regulates amino acid biosynthesis as a component of the TOR pathway. J. Cell. Biol. 2003; 161: 333–347, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Matsumoto S., Bandyopadhyay A., Kwiatkowski D. J., Maitra U., Matsumoto T. Role of the Tsc1-Tsc2 complex in signaling and transport across the cell membrane in the fission yeast schizosaccharomyces pombe. Genetics 2002; 161: 1053–1063, [PUBMED], [INFOTRIEVE], [CSA]
- van Slegtenhorst M., Carr E., Stoyanova R., Kruger W. D., Henske E. P. Tsc1 + and tsc2 + regulate arginine uptake and metabolism in Schizosaccharomyces pombe. J. Biol. Chem. 2004; 279: 12706–12713, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Kleymenova E., Ibraghimov-Beskrovnaya O., Kugoh H., Everitt J., Xu H., Kiguchi K., Landes G., Harris P., Walker C. Tuberin-dependent membrane localization of polycystin-1: a functional link between polycystic kidney disease and the TSC2 tumor suppressor gene. Mol. Cell 2001; 7: 823–832, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Hanaoka K., Qian F., Boletta A., Bhunia A. K., Piontek K., Tsiokas L., Sukhatme V. P., Guggino W. B., Germino G. G. Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents. Nature 2000; 408: 990–994, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Conrad P. A., Smart E. J., Ying Y. S., Anderson R. G., Bloom G. S. Caveolin cycles between plasma membrane caveolae and the Golgi complex by microtubule-dependent and microtubule-independent steps. J. Cell. Biol. 1995; 131: 1421–1433, [PUBMED], [INFOTRIEVE]
- Eng C. PTEN: one gene, many syndromes. Hum. Mutat. 2003; 22: 183–198, [PUBMED], [INFOTRIEVE]
- Haruta T., Uno T., Kawahara J., Takano A., Egawa K., Sharma P. M., Olefsky J. M., Kobayashi M. A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1. Mol. Endocrinol. 2000; 14: 783–794, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Carlson C. J., White M. F., Rondinone C. M. Mammalian target of rapamycin regulates IRS-1 serine 307 phosphorylation. Biochem. Biophys. Res. Commun. 2004; 316: 533–539, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Shaw R. J., Kosmatka M., Bardeesy N., Hurley R. L., Witters L. A., DePinho R. A., Cantley L. C. The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc. Natl. Acad. Sci. U. S. A. 2004; 101: 3329–3335, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Lizcano J. M., Goransson O., Toth R., Deak M., Morrice N. A., Boudeau J., Hawley S. A., Udd L., Makela T. P., Hardie D. G., et al. LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. EMBO J. 2004; 23: 833–843, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Hemminki A., Markie D., Tomlinson I., Avizienyte E., Roth S., Loukola A., Bignell G., Warren W., Aminoff M., Hoglund P., et al. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature 1998; 391: 184–187, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Harris T. E., Lawrence J. C., Jr. TOR signaling. Sci. STKE 2003; 2003: re15, [PUBMED], [INFOTRIEVE]
- Oshiro N., Yoshino K., Hidayat S., Tokunaga C., Hara K., Eguchi S., Avruch J., Yonezawa K. Dissociation of raptor from mTOR is a mechanism of rapamycin-induced inhibition of mTOR function. Genes Cells 2004; 9: 359–366, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Podsypanina K., Lee R. T., Politis C., Hennessy I., Crane A., Puc J., Neshat M., Wang H., Yang L., Gibbons J., et al. An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten +/− mice. Proc. Natl. Acad. Sci. U. S. A. 2001; 98: 10320–10325, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Neshat M. S., Mellinghoff I. K., Tran C., Stiles B., Thomas G., Petersen R., Frost P., Gibbons J. J., Wu H., Sawyers C. L. Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR. Proc. Natl. Acad. Sci. U. S. A. 2001; 98: 10314–10319, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Clark G. J., Kinch M. S., Rogers-Graham K., Sebti S. M., Hamilton A. D., Der C. J. The Ras-related protein Rheb is farnesylated and antagonizes Ras signaling and transformation. J. Biol. Chem. 1997; 272: 10608–10615, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Lepourcelet M., Chen Y. N., France D. S., Wang H., Crews P., Petersen F., Bruseo C., Wood A. W., Shivdasani R. A. Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex. Cancer Cell 2004; 5: 91–102, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Dabora S. L., Roberts P., Nieto A., Perez R., Jozwiak S., Franz D., Bissler J., Thiele E. A., Sims K., Kwiatkowski D. J. Association between a high-expressing interferon-gamma allele and a lower frequency of kidney angiomyolipomas in TSC2 patients. Am. J. Hum. Genet. 2002; 71: 750–758, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]